JK5G postbiotics attenuate immune-related adverse events in NSCLC patients by regulating gut microbiota: a randomized controlled trial in China

JK5G postbiotics attenuate immune-related adverse events in NSCLC patients by regulating gut microbiota: a randomized controlled trial in China

ScopeThis study aimed to evaluate the effects of JK5G postbiotics to regulate imbalanced gut microbiota and its impacts on the efficacy and incidence rate of immune-related adverse events (irAEs) in non-small-cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (ICIs).MethodsT...

Full description

Bibliographic Details
Main Authors: Mengting Chen, Liling Ma, Huiqing Yu, Shaoyi Huang, Junhui Zhang, Juan Gong, Liejun Yang, Lan Chen, Haojun Luo, Ling Tian, Sixiong Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Oncology
Subjects:
postbiotics
gut microbiota
immune-related adverse events
non-small-cell lung cancer
enterotype
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1155592/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1155592/full

Similar Items